One year activity of the TRP AP-HP center: Impact of [F-18]-FDG PET on the medical decision-making in oncology;Un an d'activité du centre TRP AP-HP; impact de la TEP au [18F]-FDG sur la décision médicale en cancérologie

Medecine Nucleaire

Volumn 25, Issue 10, 2001, Pages 609-619

  Talbot, J N ^a   Montravers, F ^a   Grahek, D ^a   Vaylet, C ^a   Itti, E ^a   Peker, C ^a   Benelhadj, S ^a   Nguyen, C ^a   Duet, M ^a   Toubert, M E ^a   Malek, Z ^a   Zanotti, P ^a   Kerrou, K ^a   Younsi, N ^a   Cailleux, N ^a  

^a HÔPITAL TENON   (France)

Author keywords

Clinical impact; Colon cancer; FDG; Head and neck cancers; Lung cancer; Lymphoma; Patient's management; PET

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

CALCULATION; CANCER; CANCER DIAGNOSIS; CANCER STAGING; CANCER THERAPY; CLINICAL PROTOCOL; CLINICAL TRIAL; COLON CANCER; CONFERENCE PAPER; DIAGNOSTIC IMAGING; DIAGNOSTIC PROCEDURE; FRANCE; HEAD CANCER; HEALTH CARE DELIVERY; HUMAN; LUNG CANCER; LYMPHOMA; MAJOR CLINICAL STUDY; MEDICAL DECISION MAKING; META ANALYSIS; NECK CANCER; PATIENT REFERRAL; POSITRON EMISSION TOMOGRAPHY; QUESTIONNAIRE;

EID: 0035203339     PISSN: 09281258     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (6)

1. Impact of 18F-FDG PET on managing patients with colorectal cancer: The referring physician's perspective
2. A tabulated summary of the FDG PET literature
3. Prospective survey of referring physicians to determine the impact of whole body FDG-PET on management of cancer patients
4. Substantial impact of FDG PET on re-staging of lung cancer: The referring physician perspective
5. FDG-PET influences the clinical management of lymphoma patients
6. Impact of FDG-PET on management of patients with melanoma